146 related articles for article (PubMed ID: 34099236)
1. [Management of pediatric leukemia].
Héritier S; Marquis N; Leverger G
Soins Pediatr Pueric; 2021; 42(320):35-40. PubMed ID: 34099236
[TBL] [Abstract][Full Text] [Related]
2. [Infant acute leukemia].
Brethon B; Cavé H; Fahd M; Baruchel A
Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
[TBL] [Abstract][Full Text] [Related]
3. [Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)].
Saultier P; Simonin M; Beaumais TA; Rialland F; Alby-Laurent F; Lubnau M; Desplantes C; Jacqz-Aigrain E; Rohrlich P; Reguerre Y; Rabian F; Sirvent N; Plat GW; Petit A
Bull Cancer; 2022 Nov; 109(11):1132-1143. PubMed ID: 35863954
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of leukaemia in paediatric haematology day hospital].
Héritier S; Morand K; Courcoux MF; Leverger G
Soins Pediatr Pueric; 2015; (285):17-21. PubMed ID: 26183094
[TBL] [Abstract][Full Text] [Related]
5. [Adolescents and young adults with acute lymphoblastic leukemia. A specific management].
Boissel N; Ducassou S
Bull Cancer; 2017; 104(7-8):683-689. PubMed ID: 28576259
[TBL] [Abstract][Full Text] [Related]
6. [CAR-T cells in acute lymphoblastic leukemias: What's new?].
Grain A; Dourthe ME; Baruchel A
Bull Cancer; 2020 Feb; 107(2):234-243. PubMed ID: 32035651
[TBL] [Abstract][Full Text] [Related]
7. [ALL in adult patients: Contribution and limits of pediatric management].
Rabian F; Boissel N
Bull Cancer; 2021 Feb; 108(2):187-197. PubMed ID: 32981690
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Dourthe MÉ; Yakouben K; Chaillou D; Lesprit E; Dalle JH; Baruchel A
Bull Cancer; 2018 Dec; 105 Suppl 2():S147-S157. PubMed ID: 30686353
[TBL] [Abstract][Full Text] [Related]
9. Childhood and adolescent lymphoid and myeloid leukemia.
Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
[TBL] [Abstract][Full Text] [Related]
10. Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study.
Deconinck E; Hunault M; Milpied N; Bernard M; Renaud M; Desablens B; Delain M; Witz F; Lioure B; Pignon B; Guyotat D; Berthou C; Jouet JP; Casassus P; Ifrah N; Boiron JM
Biol Blood Marrow Transplant; 2005 Jun; 11(6):448-54. PubMed ID: 15931633
[TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood leukemias.
Pui CH; Crist WM
Curr Opin Oncol; 1995 Jan; 7(1):36-44. PubMed ID: 7696362
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.
Perel Y; Auvrignon A; Leblanc T; Michel G; Reguerre Y; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Méchinaud F; Lejars O; Piguet C; Couillaud G; Pautard B; Landman-Parker J; Thuret I; Aladjidi N; Baruchel A; Leverger G;
Leukemia; 2005 Dec; 19(12):2082-9. PubMed ID: 16121218
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Rahal I; Cabannes-Hamy A; Boissel N
Bull Cancer; 2018 Dec; 105 Suppl 2():S158-S167. PubMed ID: 30686354
[TBL] [Abstract][Full Text] [Related]
14. Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.
Reman O; Buzyn A; Lhéritier V; Huguet F; Kuentz M; Stamatoullas A; Delannoy A; Fegueux N; Micléa JM; Boiron JM; Vernant JP; Gardin C; Hacini M; Georges M; Fière D; Thomas X;
Hematol J; 2004; 5(2):123-9. PubMed ID: 15048062
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
16. [Chimeric antigen receptors T cells in treatment of a relapsed pediatric acute lymphoblastic leukemia, relapse after allogenetic hematopoietic stem cell transplantation: case report and review of literature review].
Zuo Y; Wang J; Lu A; Jia Y; Wu J; Dong L; Chang L; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):115-8. PubMed ID: 27014980
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Lang P; Handgretinger R; Niethammer D; Schlegel PG; Schumm M; Greil J; Bader P; Engel C; Scheel-Walter H; Eyrich M; Klingebiel T
Blood; 2003 Feb; 101(4):1630-6. PubMed ID: 12393439
[TBL] [Abstract][Full Text] [Related]
18. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
19. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
[TBL] [Abstract][Full Text] [Related]
20. CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.
Liu J; Zhang X; Zhong JF; Zhang C
Immunotherapy; 2017 Oct; 9(13):1115-1125. PubMed ID: 29032733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
